Development of Effective PET and SPECT Imaging Agents for the Serotonin Transporter: Has a Twenty-Year Journey Reached its Destination?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|15|1499-1526

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.15, 2010-10, pp. : 1499-1526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PET and SPECT Imaging of the NMDA Receptor System: An Overview of Radiotracer Development

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-08 ,pp. : 870-886

Bentham Science Publishers

Access to resources Recommend Favorite

PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development

By  

Current Drug Targets, Vol. 16, Iss. 6, 2015-01 ,pp. : 582-591

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

By Klein N.   Sacher J.   Geiss-Granadia T.   Attarbaschi T.   Mossaheb N.   Lanzenberger R.   Pötzi C.   Holik A.   Spindelegger C.   Asenbaum S.   Dudczak R.   Tauscher J.   Kasper S.  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 263-272

Springer Publishing Company

Access to resources Recommend Favorite

Quantification of SPECT and PET for Drug Development

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 17-21

Bentham Science Publishers

Access to resources Recommend Favorite

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development

By Talbot P.S.   Laruelle M.  

European Neuropsychopharmacology, Vol. 12, Iss. 6, 2002-12 ,pp. : 503-511

Elsevier

Access to resources Recommend Favorite